Topotecan weekly bolus chemotherapy for relapsed platinum-sensitive ovarian and peritoneal cancers

OBJECTIVE: Topotecan at a dose of 1.5 mg/m(2) on days 1 to 5 of a 21-day cycle is an approved therapy for recurrent ovarian cancer. However, heavily pretreated patients may be predisposed to hematologic adverse events. This prospective study, therefore, investigates the safety and efficacy of an alt...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Morris, Robert, Alvarez, Ronald D., Andrews, Stephen, Malone, John, Bryant, Christopher, Heilbrun, Lance K., Smith, Daryn, Schimp, Veronica, Munkarah, Adnan
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3865862/
https://ncbi.nlm.nih.gov/pubmed/18410954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2008.02.028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados